Page last updated: 2024-09-05

deferasirox and Bone Marrow Diseases

deferasirox has been researched along with Bone Marrow Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kohgo, Y; Kojima, S; Matsumura, I; Miyazaki, Y; Nakao, S; Niitsu, Y; Ohyashiki, K; Ozawa, K; Suzuki, T; Tomonaga, M1

Reviews

1 review(s) available for deferasirox and Bone Marrow Diseases

ArticleYear
Japanese epidemiological survey with consensus statement on Japanese guidelines for treatment of iron overload in bone marrow failure syndromes.
    International journal of hematology, 2008, Volume: 88, Issue:1

    Topics: Asian People; Benzoates; Bone Marrow Diseases; Data Collection; Deferasirox; Erythrocyte Transfusion; Humans; Iron Chelating Agents; Iron Overload; Japan; Practice Guidelines as Topic; Syndrome; Triazoles

2008